A combination strategy targeting enhancer plasticity exerts synergistic lethality against BETi-resistant leukemia cells
Epigenetic changes can drive drug resistance in cancer. Here, the authors show that in BET inhibitor resistant leukaemia cells, genome-wide enhancer remodelling drives therapeutic resistance and targeting enhancer plasticity may overcome this resistance.
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/cd93c24dbe33431eb092362dd139a9cb |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|